Latest News

Evidence weighed for suicide/self-harm with obesity drugs


 

Is it the weight loss, rather than the meds? Seen with bariatric surgery too

Speculating what the link, if any, might be, Dr. Lofton suggested dopamine release could be playing a role. Small trials in humans as well as animal studies hint at a blunting of dopamine responses to usual triggers – including addictive substances and possibly food – that may also affect mood.

Young people (aged 18-34) who undergo bariatric surgery are at an increased risk of suicide during follow-up compared to their peers who don’t have surgery. And a study found an increase in events involving self-harm after bariatric surgery, especially among patients who already had a mental health disorder.

For a patient who derives comfort from food, not being able to eat in response to a stressful event may lead that patient to act out in more serious ways, according to Dr. Lofton. “That’s why, again, surgical follow-up is so important and their presurgical psychiatric evaluation is so important.”

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

‘Artificial pancreas’ for all type 1 diabetes pregnancies?
MDedge Endocrinology
COORDINATE-Diabetes: A ‘wake-up call’ for many specialties
MDedge Endocrinology
Education before Ramadan key to safe fasting with diabetes
MDedge Endocrinology
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
MDedge Endocrinology
Treating obesity: Will new drugs end the crisis?
MDedge Endocrinology
Weighing childhood obesity interventions
MDedge Endocrinology
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
MDedge Endocrinology
FDA approves cognitive-behavioral app for adults with type 2 diabetes
MDedge Endocrinology
Link between low co-pays for new diabetes drugs and patient adherence
MDedge Endocrinology
FDA clears the Tandem Mobi insulin pump
MDedge Endocrinology